Clinical Variant of Serpentine Supravenous Hyperpigmentation Following Subcutaneous Bortezomib Injection
This case is unique since subcutaneous administration of chemotherapeutic agents has never been reported to cause SSH. Additionally, bortezomib has not been reported as a common causative agent of this reaction.
Authors
- Madelyn Richards
- Stephen E. Weis
Institutions
- University of North Texas (US)
- University of North Texas Health Science Center (US)
Publication Details
- Journal
- HCA Healthcare Journal of Medicine
- Published
- 2024-12-31
- DOI
- https://doi.org/10.36518/2689-0216.1708
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00